Health-care companies ticked down as a rotation to other defensive sectors offset deal activity.
Investment firm CD&R and drug wholesaler McKesson agreed to buy Option Care Health, a provider of infusions to patients at home, for about $5.8 billion including debt.
Defensive-minded investors rotated back into the utility sector due to a nuclear deal.
Becton Dickinson, a maker of medical technology and hospital supplies, struck a deal with the Trump administration to invest $19 billion in the U.S. in exchange for relief from future tariffs.
The U.S. has warned Moscow that its failure to disclose details about the death of a lab worker from a plague research center in Siberia runs counter to its international health obligations, U.S. officials said.
Comments